Because serum GFAP levels have been shown to increase also in non-dementing conditions causing neuronal damage [73,74,75], they may eventually provide similar utility as NfL levels in the diagnostics of dementia, i.e., in reflecting the activity and prognosis of the neurodegenerative process. This evidence concerns the gene NEFL and dementia.